Liège, Belgium 31 October 2016 – Mithra Pharmaceuticals, a company dedicated to Women’s Health, announces that it has come to a common agreement to end the contractual relationship with its CFO Steven Peters as of today. Mr Peters will remain partly on board during a transition period of 6 months in which he will support and assist the company in its search for a replacer. During this period he will be no longer part of the Executive Committee and his responsabilities will be assumed by the CEO.